Peptide Synthesis Specialist -PEPTIDE Institute products-
2-NBDG & 2-NBDLG
2-[N-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-yl)Amino]-2-Deoxy-D-Glucose [2-NBDG] is a fluorescent tracer for monitoring D-Glucose uptake into single, living cells. In addition to this widely used product, its antipodal control compound, 2-[N-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-yl)Amino]-2-Deoxy-L-Glucose [2-NBDLG] is exclusively available applying newly developed synthetic method by Peptide Institute, Inc.
References
- Biochim. Biophys. Acta, 1289, 5 (1996).
- J. Biol. Chem., 275, 22278 (2000).
- Proc. Natl. Acad. Sci. U.S.A., 101, 12899 (2004).
- Cell, 123, 1307 (2005).
- Nat. Protoc., 2, 753 (2007).
- Proc. Natl. Acad. Sci. U.S.A., 101, 14937 (2004).
- J. Neurosci. Res., 83, 996 (2006).
- Glia, 55, 1222 (2007).
- Patent Number：6019500
- Human Cell, 29, 37 (2016). DOI: 10.1007/s13577-015-0125-3
- Org. Lett., 18, 1338 (2016). (Chem. Synthesis & Glucose Uptake in Living Cells)
- Patent WO2015156264 A1.
Product List
- Open All
- Close All
This compound is distributed through Peptide Institute, Inc. under the license of Hirosaki University Graduate School of Medicine, Tokyo University of Agriculture and Technology, and Peptide Institute, Inc.
For research use or further manufacturing use only. Not for use in diagnostic procedures.
Product content may differ from the actual image due to minor specification changes etc.
If the revision of product standards and packaging standards has been made, there is a case where the actual product specifications and images are different.